Neth Heart J. 2001 Aug;9(4):166-171.
Prognostic significance of nonfatal myocardial reinfarction in survivors of a first infarction.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
R T van Domburg, J W Deckers, P F M M van Bergen, A J Azar, J J C Jonker, M L Simoons
PMID: 25696720
PMCID: PMC2499631
Abstract
BACKGROUND: Patients who develop a reinfarction are at increased risk for subsequent reinfarctions and death. However, follow-up studies in these patients are rare.
OBJECTIVE: The purpose of this study was to examine the risk of mortality after a first myocardial reinfarction and to determine the independent contribution of nonfatal reinfarction to the risk of subsequent mortality.
METHODS: The prognostic value of nonfatal reinfarction was assessed in a large series (n=3097) of patients with a first myocardial infarction who participated in the ASPECT trial, comparing coumarin or matching placebo.
RESULTS: A second myocardial infarction was documented in 299 patients (82% Q-wave infarctions), 45 (15%) of which were fatal. Of the 254 nonfatal reinfarctions, 31 patients (12%) died during subsequent follow-up. After adjustment for baseline characteristics, the relative risks of nonfatal reinfarction for subsequent cardiac mortality at one month were: 2.90 (1.49-5.64), at one year: 2.50 (1.47-4.23) and at three years: 2.71 (1.77-4.17). Rates of death or a second reinfarction in patients who did not undergo a revascularisation procedure after a first reinfarction were almost three times higher than in patients who did have PTCA or bypass surgery after a reinfarction (38% versus 14%; p<0.0001).
CONCLUSION: This study population with three-year follow-up confirms that nonfatal reinfarction carries a strong and independent risk for recurrent reinfarction and subsequent mortality. Thus, prevention of reinfarction by intensive treatment might contribute in reduction of mortality.
Keywords: mortality; myocardial infarction; prognosis; revascularisation; risk factors
References
- J Am Coll Cardiol. 1984 Oct;4(4):695-702 - PubMed
- N Engl J Med. 1987 Sep 3;317(10):581-8 - PubMed
- J Am Coll Cardiol. 1996 Apr;27(5):1007-19 - PubMed
- J Am Coll Cardiol. 2000 Jul;36(1):51-8 - PubMed
- Eur Heart J. 1999 Aug;20(15):1112-9 - PubMed
- Ann Intern Med. 1992 Feb 1;116(3):223-37 - PubMed
- N Engl J Med. 1998 Jun 18;338(25):1785-92 - PubMed
- Am J Cardiol. 1993 Oct 15;72(12):883-8 - PubMed
- Am J Cardiol. 1990 Sep 1;66(5):538-45 - PubMed
- Heart. 1999 Oct;82(4):426-31 - PubMed
- N Engl J Med. 1989 Mar 9;320(10):618-27 - PubMed
- J Am Coll Cardiol. 1995 Oct;26(4):900-7 - PubMed
- Circulation. 1997 Aug 5;96(3):748-55 - PubMed
- J Am Coll Cardiol. 1999 Dec;34(7):1954-62 - PubMed
- N Engl J Med. 1990 Mar 15;322(11):743-53 - PubMed
- Eur Heart J. 1998 Jul;19(7):1034-41 - PubMed
- J Am Coll Cardiol. 1995 Dec;26(7):1643-50 - PubMed
- J Am Coll Cardiol. 1994 Sep;24(3):608-15 - PubMed
- Lancet. 1988 Jan 30;1(8579):197-203 - PubMed
- Circulation. 1996 Oct 1;94(7):1528-36 - PubMed
- J Am Coll Cardiol. 1990 Feb;15(2):253-8 - PubMed
- Am J Cardiol. 1984 Feb 1;53(4):408-13 - PubMed
- Am Heart J. 1991 Feb;121(2 Pt 1):457-65 - PubMed
- Acta Med Scand. 1977;201(4):309-16 - PubMed
Publication Types